Sulfasalazine and Lopid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sulfasalazine (sulfasalazine) and Lopid (gemfibrozil). Common drug interactions include body mass index increased among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Sulfasalazine and Lopid. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Sulfasalazine?

Sulfasalazine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 96,787 Sulfasalazine users. Check the latest studies of Sulfasalazine.

What is Lopid?

Lopid has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 9,700 Lopid users. Check the latest studies of Lopid.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

16 people who take Sulfasalazine and Lopid together, and have interactions are studied.

Sulfasalazine and Lopid drug interactions.

What are the common drug interactions of Sulfasalazine and Lopid, by gender? *:

female:

Body mass index increased
Abdominal abscess (collection of pus in abdomen)
Abscess (pus)
Inflammation
Post procedural infection
Abscess limb (limb infection)
Administration site reaction
Aphonia (inability to produce voice)
Diarrhoea
Drug ineffective

male:

Abdominal pain
Alanine aminotransferase increased
Gout (uric acid crystals building up in the body)
Hepatocellular damage (liver damage)
Infectious mononucleosis (infection usually caused by the epstein-barr virus)
Injection site pain
Myalgia (muscle pain)
Nausea (feeling of having an urge to vomit)
Blood bilirubin increased
Hepatomegaly (abnormal enlargement of the liver)

What are the common drug interactions of Sulfasalazine and Lopid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Injection site pain

30-39:

n/a

40-49:

Abdominal abscess (collection of pus in abdomen)
Abscess (pus)
Inflammation
Post procedural infection
Abscess limb (limb infection)
Administration site reaction
Gangrene (body tissue dies)
Gingivitis (inflammation of gums)
Hyperkeratosis (thickening of the outer layer of the skin)
Pain

50-59:

Body mass index increased
Abdominal pain
Alanine aminotransferase increased
Arthralgia (joint pain)
Blood bilirubin increased
Hepatocellular damage (liver damage)
Hepatomegaly (abnormal enlargement of the liver)
Hoarseness (changing voice)
Infectious mononucleosis (infection usually caused by the epstein-barr virus)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

60+:

Abdominal pain
Alanine aminotransferase increased
Pyrexia (fever)
Rash pruritic (redness with itching)
Vomiting
Aphonia (inability to produce voice)
Blood bilirubin increased
Cellulitis (infection under the skin)
Gout (uric acid crystals building up in the body)
Hepatomegaly (abnormal enlargement of the liver)

What are the existing conditions these people have? *

Pain: 7 people, 43.75%
Neck Pain: 5 people, 31.25%
Headache (pain in head): 4 people, 25.00%
Itching: 4 people, 25.00%
Migraine (headache): 4 people, 25.00%
Nausea (feeling of having an urge to vomit): 4 people, 25.00%
Nausea And Vomiting: 4 people, 25.00%
Wheezing (a high-pitched whistling sound made while you breath): 4 people, 25.00%
Diabetes: 4 people, 25.00%
Rashes (redness): 4 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sulfasalazine and Lopid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously